Recently, the DAOA gene locus on chromosome 13q32-q34 has been implicated in the etiology of schizophrenia. We genotyped three single-nucleotide polymorphisms (SNPs: rs778294, rs779293 and rs3918342) in this region in 126 Chinese family trios. In this study, we have identified statistically significant transmission disequilibrium in two markers rs778293 (P=0.01) and rs3918342 (P=0.02), and a highly significant under-transmission between haplotype CAT (P=0.0005) and schizophrenia. The results provide further evidence to support that DAOA gene locus is involved in conferring susceptibility to schizophrenia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.neulet.2009.06.070 | DOI Listing |
Neuropsychiatr Dis Treat
November 2023
Psychological Department, Guangdong Mental Health Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, People's Republic of China.
J Neurooncol
January 2022
Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, One Baylor Plaza, Mailstop BCM305, Houston, TX, 77030, USA.
Purpose: Impaired neurocognitive function (NCF) is extremely common in patients with higher grade primary brain tumor. We previously reported evidence of genetic variants associated with NCF in glioma patients prior to treatment. However, little is known about the effect of genetic variants on NCF decline after adjuvant therapy.
View Article and Find Full Text PDFInt J Mol Sci
October 2021
Institute of Clinical Medical Science, China Medical University, Taichung 40402, Taiwan.
Numerous studies over the last several years have shown that d-amino acids, especially d-serine, have been related to brain and neurological disorders. Acknowledged neurological functions of d-amino acids include neurotransmission and learning and memory functions through modulating -methyl-d-aspartate type glutamate receptors (NMDARs). Aberrant d-amino acids level and polymorphisms of genes related to d-amino acids metabolism are associated with neurodegenerative brain conditions.
View Article and Find Full Text PDFAnn Palliat Med
September 2021
National Clinical Research Center for Mental Disorders, and Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, China.
Schizophrenia is a common psychotic disease worldwide, and several genetic variants have been suggested to influence susceptibility to schizophrenia. However, the exact genetic and neural mechanisms underlying such relationships remain unclear. Neuroimaging endophenotypes have been considered to be desirable for finding genes influencing brain structure and function.
View Article and Find Full Text PDFCurr Pharm Des
October 2021
Institute of Neurosciences of Castilla y Leon (INCYL), Laboratory of Neuroanatomy of the Peptidergic Systems, (Group GIR-BMD), University of Salamanca, 37007-Salamanca, Spain.
Background: Schizophrenia is a chronic mental illness that in 80% of cases has a genetic etiology. In the last years, 260 risk genes with a predisposition to schizophrenia have been discovered and correlations between risk genes and the therapeutic efficacy of an antipsychotic treatment/pharmacotherapy resistance have been reported.
Objective: The objective of this review is to update the main risk genes involved in schizophrenia and to establish an association between the single nucleotide polymorphisms (SNPs) of these genes and pharmacotherapy resistance/efficacy of a determined antipsychotic treatment.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!